Results 21 to 30 of about 5,300,714 (382)
Aging & Mental Health, 2016 Objectives: In the UK dementia is under-diagnosed, there is limited access to specialist memory clinics, and many of the patients referred to such clinics are ultimately found to have functional (non-progressive) memory disorders (FMD), rather than a ...
Danielle Jones +6 more
semanticscholar +1 more source
Memory and anxiety disorders [PDF]
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 1995 Experimental psychopathologists have identified varying patterns in memory bias in people with depressive and anxiety disorders. Individuals suffering from depression tend to exhibit explicit memory deficits for positively-valanced material, and sometimes exhibit biases for retrieving negative self-relevant information as well.
openaire +4 more sources
Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
Alzheimer’s Research & Therapy, 2018 Background The experiences of biomarker-ineligible cognitively normal persons can inform trial conduct and the translation of preclinical Alzheimer’s disease (AD) into clinical practice.
Joshua D. Grill +3 more
doaj +1 more source
Trials, 2021 Background Sensorimotor impairments of upper limb (UL) are common after stroke, leading to difficulty to use the UL in daily life. Even though many have sensory impairments in the UL, specific sensory training is often lacking in stroke rehabilitation ...
Håkan Carlsson +4 more
doaj +1 more source
Informed consent decision-making in deep brain stimulation [PDF]
, 2018 Deep brain stimulation (DBS) has proved useful for several movement disorders (Parkinson’s disease, essential tremor, dystonia), in which first and/or second line pharmacological treatments were inefficacious.
Appelbaum +6 more
core +2 more sources
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2020 Introduction We sought to examine the association of race/ethnicity with willingness to engage in studies that involve procedures typical of Alzheimer's disease (AD) clinical trials and determine whether any observed differences could be explained by ...
Christian R. Salazar +3 more
doaj +1 more source
Quantitative, High-Throughput Assays for Proteolytic Degradation of Amylin
Methods and Protocols, 2020 Amylin is a pancreatic peptide hormone that regulates glucose homeostasis but also aggregates to form islet amyloid in type-2 diabetes. Given its role in both health and disease, there is renewed interest in proteolytic degradation of amylin by insulin ...
Caitlin N. Suire +2 more
doaj +1 more source
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
Scientific Data, 2021 Measurement(s) Protein Expression • gene expression • electrophysiology data • protein measurement • behavior Technology Type(s) immunofluorescence microscopy assay • RNA sequencing • electrophysiology assay • Electrochemiluminescence Immunoassay ...
Stefania Forner +20 more
doaj +1 more source
From autism to eating disorders and more: the role of oxytocin in neuropsychiatric disorders [PDF]
, 2016 Oxytocin (oxy) is a pituitary neuropeptide hormone synthesized from the paraventricular and supraoptic nuclei within the hypothalamus. Like other neuropeptides, oxy can modulate a wide range of neurotransmitter and neuromodulator activities. Additionally,
Di Bonaventura, Maria Vittoria Micioni +3 more
core +2 more sources
Memory in autism spectrum disorder: a meta-analysis of experimental studies [PDF]
, 2020 To address inconsistencies in the literature on memory in Autism Spectrum Disorder (ASD), we report the first ever meta-analysis of short-term (STM) and episodic long-term (LTM) memory in ASD, evaluating the effects of type of material, type of retrieval
Baylete, J-M. +8 more
core +1 more source